These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9682373)

  • 1. Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response.
    Theus SA; Smulian AG; Steele P; Linke MJ; Walzer PD
    Vaccine; 1998 Jul; 16(11-12):1149-57. PubMed ID: 9682373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization.
    Smulian AG; Sullivan DW; Theus SA
    Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat.
    Theus SA; Andrews RP; Steele P; Walzer PD
    J Clin Invest; 1995 Jun; 95(6):2587-93. PubMed ID: 7769101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant major surface glycoprotein of Pneumocystis carinii elicits a specific immune response but is not protective in immunosuppressed rats.
    Lasbury ME; Angus CW; Klivington D; Durant PJ; Bartlett MS; Smith JW; Lee CH
    J Eukaryot Microbiol; 1999; 46(5):136S-137S. PubMed ID: 10519289
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine responses to the native and recombinant forms of the major surface glycoprotein of Pneumocystis carinii.
    Theus SA; Smulian AG; Sullivan DW; Walzer PD
    Clin Exp Immunol; 1997 Aug; 109(2):255-60. PubMed ID: 9276520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii.
    Theus SA; Linke MJ; Andrews RP; Walzer PD
    Infect Immun; 1993 Nov; 61(11):4703-9. PubMed ID: 8406869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii.
    Theus SA; Andrews RP; Linke MJ; Walzer PD
    J Eukaryot Microbiol; 1997; 44(2):96-100. PubMed ID: 9109259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia.
    Gigliotti F; Wiley JA; Harmsen AG
    Infect Immun; 1998 Jul; 66(7):3179-82. PubMed ID: 9632583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the expression site of the major surface glycoprotein of human-derived Pneumocystis carinii.
    Kutty G; Ma L; Kovacs JA
    Mol Microbiol; 2001 Oct; 42(1):183-93. PubMed ID: 11679077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.
    Bishop LR; Helman D; Kovacs JA
    BMC Immunol; 2012 Jul; 13():39. PubMed ID: 22788748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic p55 tandem DNA vaccine against Pneumocystis carinii in rats.
    Fan H; Guo JY; Ma SL; Zhang N; An CL
    Microbiol Immunol; 2016 Jun; 60(6):397-406. PubMed ID: 27185490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major surface glycoprotein genes from Pneumocystis carinii f. sp. ratti.
    Schaffzin JK; Garbe TR; Stringer JR
    Fungal Genet Biol; 1999 Dec; 28(3):214-26. PubMed ID: 10669586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-gene family of major surface glycoproteins of Pneumocystis carinii: full-size cDNA cloning and expression.
    Kitada K; Wada M; Nakamura Y
    DNA Res; 1994; 1(2):57-66. PubMed ID: 7584029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pneumocystis carinii major surface glycoprotein (MSG): its potential involvement in the pathophysiology of pneumocystosis.
    Benfield TL; Lundgren JD
    FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):129-34. PubMed ID: 9792071
    [No Abstract]   [Full Text] [Related]  

  • 15. Large doses of major surface glycoprotein-sensitized donor splenocytes transferred to corticosteroid treated rats with Pneumocystis pneumonia result in successful reduction of organism burden.
    Thullen TD; Walzer PD
    J Eukaryot Microbiol; 2003; 50 Suppl():666-7. PubMed ID: 14736210
    [No Abstract]   [Full Text] [Related]  

  • 16. Adoptive transfer of specific lymphocyte populations sensitized to the major surface glycoprotein of Pneumocystis carinii decreases organism burden while increasing survival rate in the rat.
    Theus SA; Walzer PD
    J Eukaryot Microbiol; 1997; 44(6):23S-24S. PubMed ID: 9508414
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic variation by positional control of major surface glycoprotein gene expression in Pneumocystis carinii.
    Wada M; Sunkin SM; Stringer JR; Nakamura Y
    J Infect Dis; 1995 Jun; 171(6):1563-8. PubMed ID: 7769293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy.
    Yale SH; Limper AH
    Mayo Clin Proc; 1996 Jan; 71(1):5-13. PubMed ID: 8538233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection.
    Fisher DJ; Gigliotti F; Zauderer M; Harmsen AG
    Infect Immun; 1991 Oct; 59(10):3372-6. PubMed ID: 1894351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to Pneumocystis jirovecii major surface glycoprotein.
    Daly KR; Huang L; Morris A; Koch J; Crothers K; Levin L; Eiser S; Satwah S; Zucchi P; Walzer PD
    Emerg Infect Dis; 2006 Aug; 12(8):1231-7. PubMed ID: 16965702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.